Neurology
-
Multicenter Study
Copeptin adds prognostic information after ischemic stroke: results from the CoRisk study.
To evaluate and validate the incremental value of copeptin in the prediction of outcome and complications as compared with established clinical variables. ⋯ In patients with ischemic stroke, copeptin is a validated blood marker that adds predictive information for functional outcome and mortality at 3 months beyond stroke severity and age. Copeptin seems to be a promising new blood marker for prediction of in-hospital complications.